Elevated CSF CX3CL1 levels in delirium and AD patients are associated with decreased synapse-associated proteins (Peters van Ton et al., 2020), suggesting disease-specific alterations in signaling dynamics. Here, CX3CL1 is linked to Alzheimer disease.